+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Spinal Cord Injury Drug"

Spinal Cord Injury - Pipeline Insight, 2021 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 80 Pages
  • Global
From
Chronic Spinal Cord Injury - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Spinal Cord Injury - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Spinal Cord Injury (SCI) - Epidemiology forecast - 2030 - Product Thumbnail Image

Spinal Cord Injury (SCI) - Epidemiology forecast - 2030

  • Report
  • January 2021
  • 80 Pages
  • Global
From
Chronic Spinal Cord Injury - Pipeline Insight - 2020 - Product Thumbnail Image

Chronic Spinal Cord Injury - Pipeline Insight - 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
From
From
From
Spinal Cord Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Spinal Cord Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 264 Pages
  • Global
From
From
From
From
From
Spinal Cord Injury Market Report and Forecast 2024-2032 - Product Thumbnail Image

Spinal Cord Injury Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator

The Spinal Cord Injury Drug market is a subset of the Central Nervous System Drugs market, which focuses on treatments for diseases and disorders of the brain and spinal cord. Spinal Cord Injury Drugs are used to treat a variety of conditions, including traumatic spinal cord injury, spinal cord tumors, and spinal cord compression. These drugs are designed to reduce inflammation, improve nerve function, and promote healing. They may also be used to reduce pain and improve mobility. The Spinal Cord Injury Drug market is highly competitive, with many companies developing and marketing treatments for these conditions. Some of the major players in this market include Pfizer, Novartis, Merck, and Johnson & Johnson. Other companies, such as AbbVie, Sanofi, and AstraZeneca, are also active in this market. Show Less Read more